2 Reasons to Watch AME and 1 to Stay Cautious

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

AME Cover Image

Over the past six months, AMETEK has been a great trade, beating the S&P 500 by 10.1%. Its stock price has climbed to $232.45, representing a healthy 21.6% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Is now still a good time to buy AME? Or is this a case of a company fueled by heightened investor enthusiasm? Find out in our full research report, it’s free.

Why Does AME Stock Spark Debate?

Started from its humble beginnings in motor repair, AMETEK (NYSE: AME) manufactures electronic devices used in industries like aerospace, power, and healthcare.

Two Positive Attributes:

1. Skyrocketing Revenue Shows Strong Momentum

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can have short-term success, but a top-tier one grows for years. Luckily, AMETEK’s sales grew at an impressive 10.8% compounded annual growth rate over the last five years. Its growth beat the average industrials company and shows its offerings resonate with customers.

AMETEK Quarterly Revenue

2. Excellent Free Cash Flow Margin Boosts Reinvestment Potential

Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

AMETEK has shown terrific cash profitability, putting it in an advantageous position to invest in new products, return capital to investors, and consolidate the market during industry downturns. The company’s free cash flow margin was among the best in the industrials sector, averaging 21.6% over the last five years.

AMETEK Trailing 12-Month Free Cash Flow Margin

One Reason to be Careful:

Projected Revenue Growth Is Slim

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect AMETEK’s revenue to rise by 7.1%, close to its 10.8% annualized growth for the past five years. This projection is underwhelming and indicates its newer products and services will not lead to better top-line performance yet. At least the company is tracking well in other measures of financial health.

Final Judgment

AMETEK has huge potential even though it has some open questions, and with its shares outperforming the market lately, the stock trades at 27.9× forward P/E (or $232.45 per share). Is now the right time to buy? See for yourself in our comprehensive research report, it’s free.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  262.07
-5.15 (-1.93%)
AAPL  300.97
+2.76 (0.93%)
AMD  432.82
-16.88 (-3.75%)
BAC  49.45
-0.40 (-0.79%)
GOOG  392.37
-4.80 (-1.21%)
META  613.15
-5.28 (-0.85%)
MSFT  422.35
+12.92 (3.16%)
NVDA  228.02
-7.72 (-3.27%)
ORCL  192.59
-3.02 (-1.54%)
TSLA  425.12
-18.18 (-4.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.